Currently, the most widely used vaccine against TB is the Bacillus Calmette-Guérin (BCG). Developed in 1921, the vaccine ...

A new vaccine that boosts immunity against tuberculosis (TB) has been shown to be effective in pioneering pre-clinical trials ...

A new mRNA vaccine against tuberculosis (TB) is showing favorable results in preclinical trials. With only one currently ...

A new vaccine that boosts immunity against tuberculosis (TB) has been shown to be effective in pioneering pre-clinical trials. A new vaccine that boosts immunity against tuberculosis (TB ...

Australian researchers have developed a new mRNA vaccine for tuberculosis, showing effective results in mice. The vaccine enhances immunity and offers better long-term protection compared to the ...

A new vaccine that boosts immunity against tuberculosis (TB) has been shown to be effective in pioneering pre-clinical trials, as part of a successful collaboration between three leading Australian ...

A novel vaccine that boosts immunity against tuberculosis (TB) has been shown to be effective in pioneering pre-clinical trials. The study found the vaccine was effective in triggering an immune ...

The current status of TB vaccine development and testing is very encouraging. Several new TB vaccines are currently in Phase I or IIa human trials and field sites for eventual Phase III efficacy ...

Wassiti, Monash Institute of Pharmaceutical SciencesA novel vaccine that boosts immunity against tuberculosis (TB) has been shown to be ...

GlaxoSmithKline has spent 20 years trying to develop an improved vaccine for tuberculosis, and new data for its lead candidate M72/AS01E suggests it is getting closer to a breakthrough in the disease.